Retained Earnings (Accumulated Deficit) of BIO-RAD LABORATORIES, INC. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
BIO-RAD LABORATORIES, INC. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • BIO-RAD LABORATORIES, INC. Retained Earnings (Accumulated Deficit) for the quarter ending 31 Dec 2025 was $8,176,300,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $8,176,300,000 +$759,900,000 +10% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 $7,456,300,000 -$675,931,000 -8.3% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $7,798,200,000 +$319,141,000 +4.3% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $7,480,400,000 -$2,164,145,000 -22% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $7,416,400,000 -$1,844,200,000 -20% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 $8,132,231,000 -$778,690,000 -8.7% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $7,479,059,000 -$1,325,605,000 -15% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $9,644,545,000 -$322,414,000 -3.2% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $9,260,600,000 -$637,603,000 -6.4% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $8,910,921,000 -$135,609,000 -1.5% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $8,804,664,000 -$405,793,000 -4.4% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $9,966,959,000 -$170,669,000 -1.7% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $9,898,203,000 -$3,627,140,000 -27% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q3 2022 $9,046,530,000 -$6,034,324,000 -40% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $9,210,457,000 -$1,949,018,000 -17% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $10,137,628,000 -$107,798,000 -1.1% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $13,525,343,000 +$4,257,331,000 +46% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q3 2021 $15,080,854,000 +$6,651,929,000 +79% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $11,159,475,000 +$4,036,382,000 +57% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $10,245,426,000 +$4,088,735,000 +66% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $9,268,012,000 +$3,797,233,000 +69% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 $8,428,925,000 +$3,511,612,000 +71% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $7,123,093,000 +$1,938,582,000 +37% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $6,156,691,000 +$1,570,990,000 +34% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $5,470,779,000 +$1,748,706,000 +47% 31 Dec 2019 10-K 16 Feb 2021 2020 FY
Q3 2019 $4,917,313,000 +$366,712,000 +8.1% 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $5,184,511,000 +$903,236,000 +21% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $4,585,701,000 +$572,469,000 +14% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $3,722,073,000 +$1,891,634,000 +103% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $4,550,601,000 +$2,669,836,000 +142% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 $4,281,275,000 +$2,427,903,000 +131% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $4,013,232,000 +$2,164,895,000 +117% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $1,830,439,000 +$1,858,000 +0.1% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $1,880,765,000 +$24,015,000 +1.3% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $1,853,372,000 +$15,027,000 +0.82% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $1,848,337,000 +$28,006,000 +1.5% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $1,828,581,000 +$20,526,000 +1.1% 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q3 2016 $1,856,750,000 +$98,177,000 +5.6% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $1,838,345,000 +$97,142,000 +5.6% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 $1,820,331,000 +$107,551,000 +6.3% 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 $1,808,055,000 +$113,093,000 +6.7% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $1,758,573,000 +$102,648,000 +6.2% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $1,741,203,000 +$96,787,000 +5.9% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 $1,712,780,000 +$99,995,000 +6.2% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 $1,694,962,000 +$88,845,000 +5.5% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 $1,655,925,000 +$79,944,000 +5.1% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $1,644,416,000 +$66,555,000 +4.2% 30 Jun 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 $1,612,785,000 +$69,598,000 +4.5% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $1,606,117,000 +$77,790,000 +5.1% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 $1,575,981,000 +$94,339,000 +6.4% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $1,577,861,000 +$138,603,000 +9.6% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $1,543,187,000 +$152,272,000 +11% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 $1,528,327,000 +$168,417,000 +12% 31 Dec 2012 10-K 18 Mar 2014 2013 FY
Q3 2012 $1,481,642,000 +$180,971,000 +14% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 $1,439,258,000 +$184,484,000 +15% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $1,390,915,000 +$176,189,000 +15% 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 $1,359,910,000 +$178,223,000 +15% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q3 2011 $1,300,671,000 +$186,892,000 +17% 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 $1,254,774,000 +$185,759,000 +17% 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q1 2011 $1,214,726,000 31 Mar 2011 10-Q 06 May 2011 2011 Q1
Q4 2010 $1,181,687,000 31 Dec 2010 10-K 29 Feb 2012 2011 FY
Q3 2010 $1,113,779,000 30 Sep 2010 10-Q 09 Nov 2010 2010 Q3
Q2 2010 $1,069,015,000 30 Jun 2010 10-Q 06 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.